Also published in ncbi.nlm.nih.gov:
Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.
x hide permanently

Vincristine resistance in relapsed neuroblastoma can be efficiently overcome by Smac mimetic LCL161 treatment.

ncbi.nlm.nih.gov

Vincristine resistance in relapsed neuroblastoma can be efficiently overcome by Smac mimetic LCL161 treatment.

J Pediatr Surg. 2018 Jan 31;:

Authors: Frommann K, Appl B, Hundsdoerfer P, Reinshagen K, Eschenburg G

Abstract PURPOSE: In spite of good initial therapy response neuroblastomas often spread to distant organs or relapse after periods of remission.

Mentions: Treatment Relapse